This review has comprehensively provided the anticancer potential of anthocyanins against different types of cancer, including breast, prostate, lung, liver, ovarian, and cervical cancers, by highlighting possible signaling pathways (MAPK, NF‐kB, and PI3k/Akt) and gene expression (TP53, BRCA1, and BCL‐2). This evidence concerns the gene BCL2 and cancer.